Endonovo Therapeutics, Inc.
ENDV· OTC
ENDVEndonovo Therapeutics, Inc.
Filed Apr 5, 2016 · 10-K · 96 days after period end · 0001469709-16-000755
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | — | $22.90K | $13.66K |
| Net Income | -$4.45M | -$222.93K | -$674.45K | -$660.26K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endonovo Therapeutics, Inc. · CIK 1528172 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Apr 5, 2016 · 96 d after period end
